After Trump pressured pharmaceutical companies to lower drug prices for Americans, Eli Lilly announced an increase in the UK price of the weight loss jab Mounjaro. The move aimed to align the UK price with other European markets, raising concerns about accessibility through the NHS. Trump’s push for global pricing parity stirred reactions from major drugmakers. Learn more about this significant development.
